ARLINGTON, Va.--(BUSINESS WIRE)--Surescripts®, the nation's leading health information network, has now expanded its innovative Sig IQ technology, first introduced for Medication History in 2022, to E ...

Surescripts, a health information network, has expanded its Sig IQ technology, first introduced for Medication History in 2022, to E-Prescribing transactions, including NewRx and both RxRenewal ...

SANTA CLARA, California, Aug. 15, 2018 /PRNewswire/ -- Based on its recent analysis of the North America electronic prescribing market, Frost & Sullivan recognizes Surescripts with the 2018 North ...

SANTA CLARA, Calif., Aug. 15, 2018 /CNW/ -- Based on its recent analysis of the North America electronic prescribing market, Frost & Sullivan recognizes Surescripts with the 2018 North America New ...

Surescripts is up for sale and has hired a bank to search for potential buyers, including private equity firms. The company dominates electronic prescribing, processing 2.5 billion prescriptions in ...

ARLINGTON, Va.--(BUSINESS WIRE)--Eighth paragraph, fourth sentence of release should read: ...Massachusetts (instead of ...Maine). The corrected release reads: NEARLY A QUARTER OF A MILLION ...

The case touches on some of the biggest players in pharmacy management. Surescripts is now owned by pharmacy retail giant CVS (which recently acquired Aetna and runs the PBM Caremark), Express Scripts ...

WASHINGTON (Reuters) - The U.S. Federal Trade Commission filed an antitrust lawsuit against the health information network Surescripts on Wednesday, accusing them of using illegal means to maintain ...

In its latest move to rein in what it views as anticompetitive tactics in the healthcare industry, the Federal Trade Commission filed a lawsuit against Surescripts, charging the health information ...

WASHINGTON, April 24 (Reuters) - The U.S. Federal Trade Commission filed an antitrust lawsuit against the health information network Surescripts on Wednesday, accusing them of using illegal means to ...

Electronic prescribing company Surescripts is exploring a potential sale. Surescripts, which is 50% owned by CVS Health (NYSE:CVS) and Cigna's (NYSE:CI) Express Scripts, has hired investment bank ...